Stati Uniti - Ingliż - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - trastuzumab (unii: p188anx8ck) (trastuzumab - unii:p188anx8ck) - trazimera is indicated for adjuvant treatment of her2-overexpressing node positive or node negative (er/pr negative or with one high risk feature [see clinical studies (14.1)] ) breast cancer - as part of a treatment regimen consisting of doxorubicin, cyclophosphamide, and either paclitaxel or docetaxel - as part of a treatment regimen with docetaxel and carboplatin - as a single agent following multi-modality anthracycline based therapy. select patients for therapy based on an fda-approved companion diagnostic for a trastuzumab product [see dosage and administration (2.1)] . trazimera is indicated: - in combination with paclitaxel for first-line treatment of her2-overexpressing metastatic breast cancer - as a single agent for treatment of her2-overexpressing breast cancer in patients who have received one or more chemotherapy regimens for metastatic disease. select patients for therapy based on an fda-approved companion diagnostic for a trastuzumab product [see dosage and administration (2.1)]. trazimera is

Afrika t’Isfel - Ingliż - South African Health Products Regulatory Authority (SAHPRA)

biotech laboratories (pty) ltd - tablet - see ingredients - each tablet contains ibuprofen 200,0 mg

Tanżanija - Ingliż - Tanzania Medicinces & Medical Devices Authority

unique pharmaceutical laboratories (a division of j.b. chemicals & pharmaceuticals ltd), india - nifedipine - extended release tablet - 20 mg

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

gabco imports pty ltd -

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

sabco australia - 47178 - hevea-latex surgical glove, non-powdered - the glove is a single use latex surgical glove

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

sabco australia - 47176 - vinyl examination/treatment glove, non-powdered - single use non-sterile synthetic vinyl examination glove

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

sabco australia - 56286 - nitrile examination/treatment glove, non-powdered - single use powder free non-sterile nitrile examination gloves

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

sabco australia - 56286 - nitrile examination/treatment glove, non-powdered - disposable nitrile exam gloves are used to prevent transmission of a wide variety of diseases to both patients and health care personnel, and intended for medical purpose is worn on the examiner's hand to prevent contamination between patient and examiner. this is a single use, disposable device(s), provided non-sterile.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

tabco pty ltd - riboflavine, quantity: 1.25 mg; nicotinamide, quantity: 5 mg; taraxacum officinale, quantity: 1.25 mg (equivalent: taraxacum officinale, qty 5 mg); ginkgo biloba, quantity: 0.24 microgram (equivalent: ginkgo biloba, qty 12 mg; equivalent: ginkgo flavonglycosides, qty 57.6 microgram; equivalent: ginkgolides and bilobalide, qty 14.4 microgram); fucus vesiculosus, quantity: 10 mg; calcium pantothenate, quantity: 2.75 mg; colecalciferol, quantity: 0.0019 mg; lecithin, quantity: 2.5 mg; d-alpha-tocopheryl acid succinate, quantity: 15.5 mg; ascorbic acid, quantity: 26 mg; thiamine hydrochloride, quantity: 1.25 mg; pyridoxine hydrochloride, quantity: 3 mg; biotin, quantity: 0.625 microgram; cyanocobalamin, quantity: 1.5 microgram; folic acid, quantity: 50 microgram; choline bitartrate, quantity: 10 mg; inositol, quantity: 1.25 mg; betacarotene, quantity: 0.225 mg; dl-phenylalanine, quantity: 50 mg; bioflavonoids, quantity: 2.25 mg; bacopa monnieri, quantity: 0.6 mg (equivalent: bacopa monnieri, qty 12 mg; equivalent: bacosides calculated as bacoside a (of bacopa monnieri), qty 0.27 mg); rosa canina, quantity: 1.25 mg (equivalent: rosa canina, qty 5 mg); zinc gluconate, quantity: 100 microgram; tyrosine, quantity: 225 mg; ferrous gluconate, quantity: 0.25 mg; medicago sativa, quantity: 5 mg; manganese gluconate, quantity: 25 microgram; calcium gluconate monohydrate, quantity: 15.6 mg; saccharomyces cerevisiae, quantity: 21.25 mg - capsule, hard - excipient ingredients: glucose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; calcium hydrogen phosphate dihydrate; maltodextrin; maize starch; silicon dioxide; dl-alpha-tocopherol; sucrose; hydrolysed gelatin; hydrogenated soya oil; ascorbyl palmitate; potable water; mixed (low-alpha type) tocopherols concentrate; gelatin; soya oil - aids, assists or helps in the maintenance or improvement of general well-being.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

tabco pty ltd - ascorbic acid,citrus sinensis,silicon dioxide -